Stay updated on Pralsetinib in RET+ Cancer Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib in RET+ Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Page now reflects a new release (v3.2.0) and an urgent operating-status notice due to funding gaps; an older resource topic (Medullary thyroid carcinoma) is removed.
    Difference
    1%
    Check dated 2025-10-06T04:22:19.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Core term updated: 'Medullary thyroid gland carcinoma' → 'Medullary thyroid carcinoma'; page version updated from v3.0.2 to v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-28T23:40:23.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:45:27.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T13:09:36.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, as well as additional resources related to genetic and rare diseases, particularly focusing on various types of cancers. Notably, several previous entries have been removed, including some cancer-related topics and specific location details.
    Difference
    7%
    Check dated 2025-08-31T06:19:46.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T21:41:19.000Z thumbnail image

Stay in the know with updates to Pralsetinib in RET+ Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.